BCIQ Profiles

Company Profile Report
0218 reg pdev QTs
BioCentury & Getty Images


Feb. 18 Quick Takes: Label expansion for Entresto; plus Amgen, Sesen, BeiGene, Cortexyme and more

Feb 18, 2021 | 9:22 PM GMT

Novartis AG (NYSE:NVS; SIX:NOVN) said FDA approved Entresto sacubitril/valsartan to reduce the risk of cardiovascular death and hospitalization

Read the full 446 word article

How to gain access

Continue reading with a
two-week free trial.